How many calories should I eat per day while running Trenbolone Acetate 150mg/ml?

Target calories depend on your goal phase. For lean mass, a surplus of 200–400 kcal above TDEE (calculated via Mifflin-St Jeor adjusted for activity) is the evidence-based range. For cutting, a deficit of 300–500 kcal below TDEE preserves muscle via Trenbolone Acetate's glucocorticoid receptor competition. Total calorie accuracy matters more on cycle because partitioning efficiency is heightened.

How much protein do I need daily when using Trenbolone Acetate to maximise nitrogen retention?

A daily protein intake of 2.2–2.8g per kilogram of lean body mass is consistent with nitrogen-balance optimisation studies in anabolic-assisted athletes. Trenbolone Acetate drives nitrogen retention into skeletal muscle, making dietary protein the primary rate-limiting variable. Insufficient protein directly limits the compound's anabolic output regardless of the dose administered.

Should carbohydrate intake be adjusted when on a Trenbolone Acetate cycle?

Yes — prioritise carbohydrate intake around training sessions to maximise muscle glycogen resynthesis. Trenbolone Acetate's anti-glucocorticoid activity reduces cortisol-driven breakdown between sessions, so peri-workout carbohydrate loading compounds this effect. A typical allocation is 40–60% of daily carbohydrates within two hours of training, with the remainder distributed across other meals for sustained energy.

What is the dosing volume advantage of Elite Pharm Acetate 150 at 150mg/ml compared to 100mg/ml products?

At 150mg/ml, a 0.67ml draw delivers 100mg — the dose volume is one-third smaller than a 1ml draw from a 100mg/ml vial for the same milligram amount. This concentration advantage reduces cumulative injection volume across a full cycle, which is practically significant for athletes injecting three or more times per week over eight to twelve weeks.

How should the Elite Pharm Acetate 150 10ml vial be stored after the first draw to maintain sterility?

Store the vial at 15–25°C away from direct light after first use. The bromobutyl rubber septum is designed to maintain sterile integrity across multiple aseptic draws. Use a fresh, sterile needle for every withdrawal and avoid leaving a needle inserted in the stopper between sessions. Discard if particulate matter, discolouration, or compromised seal integrity is observed. (2) angle_used

hochdosis_formel

Elite Pharm

Acetate 150 150mg/ml 10ml Vial by Elite Pharm

Name: Acetate 150
Brand: Elite Pharm
SKU: INJ-TACE-ELI-150-027
Price: 50.00 EUR
Availability: InStock

Acetate 150 by Elite Pharm is a high-concentration Trenbolone Acetate injectable formulation — 150mg per millilitre in a 10ml multi-dose vial — engineered to support calorie-controlled anabolic protocols where nutritional precision amplifies every milligram administered. Trenbolone Acetate's dual action on nitrogen retention and glucocorticoid suppression makes dietary macronutrient partitioning a decisive variable in cycle outcomes. Potency is confirmed batch-by-batch: reversed-phase HPLC assay and LAL endotoxin clearance are applied at lot level before distribution.

€50.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers 150mg of Trenbolone Acetate per millilitre — highest concentration in this product group for reduced injection volume per weekly dose.
Enhances dietary nitrogen retention in skeletal muscle, making protein intake directly productive at the tissue level.
Suppresses glucocorticoid receptor activity, protecting lean mass during caloric deficits without requiring excess protein intake.
Supports precise macronutrient partitioning — calories are directed toward muscle synthesis rather than adipose storage.
HPLC-verified batch potency ensures the dose you inject matches the dose your nutrition plan is built around.
10ml multi-dose vial format allows full cycle supply from a single, lot-traceable unit.
LAL endotoxin clearance confirmed at batch level before any vial is released for distribution.

Phase	Dosage	Note
Caloric Surplus / Lean Gaining	300–450mg/week (2–3ml from a 150mg/ml vial split across 3 injections)	Pair with 200–400 kcal surplus above TDEE; protein at minimum 2.4g/kg LBM to supply substrate for elevated nitrogen retention
Recomposition / Maintenance Calories	225–300mg/week (1.5–2ml/week split across 3 injections)	Caloric intake matched to TDEE; carbohydrates timed peri-workout to leverage glycogen resynthesis during the anabolic window
Caloric Deficit / Cutting	150–225mg/week (1–1.5ml/week)	300–500 kcal deficit below TDEE; compound's glucocorticoid suppression preserves lean tissue; protein may be reduced modestly to 2.0g/kg LBM as catabolism is blunted

Key takeaways

Calibrate daily protein to 2.2–2.8g per kg lean mass on cycle.
Set caloric surplus at 200–400 kcal above TDEE for lean gaining phases.
Prioritise peri-workout carbohydrates to compound the anti-catabolic effect.
Use the 150mg/ml concentration to reduce injection volume across long cycles.
Verify batch HPLC data before anchoring your nutrition plan to a dose target.

Trenbolone Acetate as a Nutritional Partitioning Agent

Acetate 150 by Elite Pharm delivers Trenbolone Acetate at 150mg/ml — a concentration that positions nutrition strategy, not just injection scheduling, as the primary performance lever on cycle. Trenbolone Acetate redirects dietary energy preferentially toward muscle protein synthesis, making the quality and quantity of calories consumed a direct determinant of body-composition outcomes. Compared to lower-potency 100mg/ml formulations, each millilitre drawn from Acetate 150 carries 50% more active compound, meaning caloric and protein targets must be calibrated upward proportionally to support the elevated anabolic drive.

Trenbolone Acetate enhances nitrogen retention in skeletal muscle tissue, documented via urinary nitrogen balance assays in monitored athletes. Elevated nitrogen balance signals net anabolic status — the biochemical state in which dietary protein is being incorporated into new muscle rather than oxidised for fuel. This mechanism means that protein intake becomes the rate-limiting nutritional variable: inadequate dietary protein blunts the compound's anabolic output regardless of dose.

Calorie Targets and Macronutrient Strategy

During a recomposition or lean-gaining phase, a moderate caloric surplus of 200–400 kcal above measured total daily energy expenditure (TDEE) — calculated via the Mifflin-St Jeor equation adjusted for activity factor — provides sufficient substrate without excess fat accumulation. Protein targets of 2.2–2.8g per kilogram of lean body mass per day are consistent with research-grade nitrogen-balance optimisation studies. Carbohydrate allocation should prioritise peri-workout windows to maximise muscle glycogen resynthesis while the compound's anti-glucocorticoid activity suppresses cortisol-driven protein breakdown between training sessions.

During a caloric deficit, Trenbolone Acetate's glucocorticoid receptor competition preserves lean tissue that would otherwise be catabolised — a function that makes dietary fat loss achievable without sacrificing contractile protein. A deficit of 300–500 kcal below TDEE is the evidence-based range that maintains anabolic signalling while promoting adipose mobilisation.

Quality Assurance Supporting Dose-Nutrition Synchronisation

Accurate dose delivery is non-negotiable when nutritional programming is built around a specific weekly milligram target. Elite Pharm verifies each Acetate 150 batch through reversed-phase HPLC potency assay and LAL (Limulus Amebocyte Lysate) endotoxin testing — two independent analytical gates applied at lot level. Every 10ml vial carries a batch number cross-referenced to those release records, ensuring the 150mg/ml label concentration is the actual concentration received.

Usage

Calculate your TDEE using the Mifflin-St Jeor equation before the first injection — your caloric target for the cycle phase is set against this baseline, not an estimate.
Determine your weekly protein target (2.2–2.8g per kg lean body mass) and distribute it across five to six meals daily to sustain elevated muscle protein synthesis rates throughout the day.
Draw the required volume from the Acetate 150 vial using a sterile syringe; at 150mg/ml, a 1ml draw delivers 150mg — confirm your target dose volume before each injection.
Administer via intramuscular injection into a large muscle group (glute, quad, or lateral deltoid) using aseptic technique; rotate sites across the three weekly injection days to avoid localised irritation.
Schedule your largest carbohydrate meal within two hours post-injection/post-training to align nutrient delivery with the anabolic environment the compound supports.
Track weekly body weight, tape measurements, and subjective energy to audit whether caloric intake is correctly matched to your phase target — adjust in 100–150 kcal increments based on rate of weight change.

Warnings

Contraindications: Individuals diagnosed with hepatic dysfunction, prostate carcinoma, breast carcinoma, or active cardiac pathology must not use this preparation. A haematocrit reading exceeding 52% represents an absolute contraindication prior to commencing any cycle. Confirmed hypersensitivity to trenbolone or to any constituent of the oil-based vehicle similarly precludes use. This compound is not appropriate for female patients owing to the pronounced and partially irreversible risk of virilisation. Use in persons below 21 years of age is not indicated, as endocrine maturation remains incomplete.

Side Effects: Progestogenic activity inherent to the 19-nor compound class may produce libido suppression and mood disturbance, effects that become more clinically apparent at weekly doses above 300 mg. Androgenic sequelae — comprising sebaceous hypersecretion, truncal acne, and accelerated follicular recession in genetically susceptible individuals — are concentration-dependent in their severity. Elevation of resting body temperature alongside nocturnal diaphoresis is a frequently reported tolerability issue at virtually any dose level. Adverse shifts in cardiovascular biomarkers, specifically depression of HDL and elevation of LDL alongside haematocrit increases, necessitate active surveillance across the full duration of the cycle.

Monitoring: Prior to commencing the cycle, a comprehensive blood panel must be obtained, encompassing ALT, AST, lipid fractions, haematocrit, and serum testosterone as baseline reference values. Repeat assessment at weeks four and eight permits timely identification of adverse haematological or hepatic trends before they become clinically significant. An upward drift in haematocrit should prompt review of weekly caloric intake, given that expanded red cell mass increases metabolic demand. Self-measurement of arterial blood pressure is recommended no fewer than twice per week throughout the cycle.

PCT: Trenbolone Acetate produces pronounced suppression of the hypothalamic-pituitary-gonadal axis, making structured post-cycle therapy obligatory upon cessation. The acetate ester is characterised by a brief active half-life; consequently, a SERM-based recovery protocol — utilising tamoxifen citrate or clomiphene citrate over four to six weeks — may be commenced approximately seven days after the last administered injection. Adequate dietary protein intake should be sustained across the entire PCT period in order to limit catabolism of lean tissue during the phase of hormonal re-establishment.

Frequently asked questions

How many calories should I eat per day while running Trenbolone Acetate 150mg/ml?: Target calories depend on your goal phase. For lean mass, a surplus of 200–400 kcal above TDEE (calculated via Mifflin-St Jeor adjusted for activity) is the evidence-based range. For cutting, a deficit of 300–500 kcal below TDEE preserves muscle via Trenbolone Acetate's glucocorticoid receptor competition. Total calorie accuracy matters more on cycle because partitioning efficiency is heightened.
How much protein do I need daily when using Trenbolone Acetate to maximise nitrogen retention?: A daily protein intake of 2.2–2.8g per kilogram of lean body mass is consistent with nitrogen-balance optimisation studies in anabolic-assisted athletes. Trenbolone Acetate drives nitrogen retention into skeletal muscle, making dietary protein the primary rate-limiting variable. Insufficient protein directly limits the compound's anabolic output regardless of the dose administered.
Should carbohydrate intake be adjusted when on a Trenbolone Acetate cycle?: Yes — prioritise carbohydrate intake around training sessions to maximise muscle glycogen resynthesis. Trenbolone Acetate's anti-glucocorticoid activity reduces cortisol-driven breakdown between sessions, so peri-workout carbohydrate loading compounds this effect. A typical allocation is 40–60% of daily carbohydrates within two hours of training, with the remainder distributed across other meals for sustained energy.
What is the dosing volume advantage of Elite Pharm Acetate 150 at 150mg/ml compared to 100mg/ml products?: At 150mg/ml, a 0.67ml draw delivers 100mg — the dose volume is one-third smaller than a 1ml draw from a 100mg/ml vial for the same milligram amount. This concentration advantage reduces cumulative injection volume across a full cycle, which is practically significant for athletes injecting three or more times per week over eight to twelve weeks.
How should the Elite Pharm Acetate 150 10ml vial be stored after the first draw to maintain sterility?: Store the vial at 15–25°C away from direct light after first use. The bromobutyl rubber septum is designed to maintain sterile integrity across multiple aseptic draws. Use a fresh, sterile needle for every withdrawal and avoid leaving a needle inserted in the stopper between sessions. Discard if particulate matter, discolouration, or compromised seal integrity is observed. (2) angle_used

Manufacturer

Elite Pharm's sourcing philosophy for Acetate 150 begins at the API procurement stage: Trenbolone Acetate raw material is selected against a vendor qualification dossier that includes certificate of analysis documentation covering identity, purity, and residual solvent limits — characteristics verified by the supplier and independently confirmed at Elite Pharm's intake testing step before any batch enters production. This upstream API control is the first link in a two-gate analytical chain: the second gate is finished-product HPLC potency assay confirming that the declared 150mg/ml concentration is present within validated tolerance limits, with LAL endotoxin data providing the parenteral safety clearance. The lot number printed on each 10ml vial ties that unit to its specific intake API records and finished-product release data — a chain of traceability that originates with raw material origin, not at the fill stage.

Product details

Brand	Elite Pharm
Active ingredient	trenbolone acetate
Also known as	Tren A, Trenbolone Acetate, Finaplix, Acetate 150, Elite Pharm Tren A
Strength	150 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TACE-ELI-150-027

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Optimal Dosage

Acro-Trenbolone 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Acro-Trenbolone is a sterile, oil-based intramuscular solution delivering Trenbolone Acetate at 100 mg per millilitre across a 10 ml multi-dose vial — engineered specifically to bypass hepatic first-pass catabolism and achieve near-complete systemic bioavailability that no oral anabolic compound can match. Because the active hormone enters circulation directly through intramuscular absorption rather than the gastrointestinal tract, essentially none of the injected dose is destroyed before it reaches target androgen receptors. Quality assurance at Beligas Pharmaceuticals is enforced through a layered release protocol: HPLC-verified potency, LAL endotoxin testing, and GMP-certified production conditions — each checkpoint documented before the vial leaves the facility.

€48.00

Trenbolin-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Trenbolin-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Trenbolin-100 is an oil-based injectable Trenbolone Acetate formulated at 100mg/ml, engineered for rapid onset of action — making it the go-to ester choice when time-to-effect and dosing efficiency both matter. Each 1ml ampoule delivers a precise, single-use dose of one of the most potent anabolic compounds available, with the acetate ester's short chain enabling plasma concentration peaks within 24–48 hours of administration. Potency is confirmed batch-to-batch via HPLC quantification; sterility is validated through LAL endotoxin screening — both conducted under GMP-certified clean-room conditions at BM Pharmaceuticals' Indian facility.

€54.00

High Concentration

TrenaTrex 150mg/ml 10ml Vial by Concentrex Labs

TrenaTrex by Concentrex Labs delivers Trenbolone Acetate at 150 mg/ml in a 10 ml multi-dose vial, engineered for athletes who demand structured, time-anchored injection scheduling to sustain stable circulating hormone levels across every training week. The acetate ester's approximately 48-hour half-life means that consistent administration timing — not rough approximation — is the primary determinant of anabolic continuity throughout a cycle. Every batch undergoes HPLC potency quantification and LAL endotoxin testing before release, confirming both the 150 mg/ml concentration and pyrogen-free sterility.

€55.00

Brand Quality

Trenbolone 100 100mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Trenbolone 100 is a single-ingredient injectable solution delivering Trenbolone Acetate at 100mg/ml across a 10ml multi-dose vial, specifically suited to frontloading strategies where a calculated loading dose accelerates the attainment of target blood levels from the very first injection day. Because the acetate ester carries one of the shortest half-lives among trenbolone esters (approximately 2–3 days), the gap between first injection and productive working concentration is inherently short — and a deliberate frontload compresses it further, letting athletes enter the active phase of a cycle days earlier than a flat-dose approach permits. Every batch of Trenbolone 100 passes HPLC potency verification and LAL endotoxin screening before release; lot-specific certificates confirm that declared concentration and sterility specifications are met across the full 10ml fill.

€46.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00